Home
Conditions
Macular Degeneration

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

197 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Macular Degeneration trial results

Enrolling by Invitation

Quest to Analyze One Thousand Humans Meditating

NCT06583395

Conditions: Adnexal Diseases, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), +213 more
Locations: VitaMed Research, LLC Palm Desert, California, United States

View Trial Details

Not Yet Recruiting

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

NCT07216924

Conditions: Blindness, Blindness, Cortical, Central Visual Impairment, +10 more
Locations: University of Minnesota Edina, Minnesota, United States

View Trial Details

Not Yet Recruiting

Artificial Intelligence-assisted Diagnosis in Ophthalmology

NCT07497815

Conditions: Cardiovascular Diseases, Cataract, Corneal Diseases, +15 more
Locations: Centro Ocular Heredia, Centro, Costa Rica

Asociados de Mácula y Vítreo de Costa Rica San José, Provincia de San José, Costa Rica

View Trial Details

Not Yet Recruiting

Vision Improvement for Patients With Age-Related Macular Degeneration

NCT06198452

Conditions: Eye Diseases, Macular Degeneration, Retinal Degeneration, +1 more
Locations: Not specified

View Trial Details

Completed

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

NCT05637255

Conditions: Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +3 more
Locations: SYL1801 Investigative Site Brno, Czechia

SYL1801 Investigative Site Chomutov, Czechia

SYL1801 Investigative Site Frýdek-Místek, Czechia

SYL1801 Investigative Site Kyjov, Czechia

View all 16 locations

View Trial Details

Completed

Ranibizumab and Reduced Fluence PDT for AMD

NCT00527475

Conditions: Eye Diseases, Macular Degeneration, Metaplasia, +5 more
Locations: California Retina Consultants & Research Foundation Santa Barbara, California, United States

Associated Retinal Consultants Ann Arbor, Michigan, United States

Texas Retina Associates Arlington, Texas, United States

View Trial Details

Completed

Scotoma Perimetry Oculomotor Training

NCT05456581

Conditions: Blindness, Blindness, Cortical, Central Visual Impairment, +11 more
Locations: UAB Birmingham, Alabama, United States

View Trial Details

Completed

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

NCT04435366

Conditions: Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations: Retina-Vitreous Associates Medical Group Beverly Hills, California, United States

Retinal Diagnostic Center Campbell, California, United States

Eye Medical Center of Fresno Fresno, California, United States

Retina Consultants of Orange County Fullerton, California, United States

View all 205 locations

View Trial Details

Completed

A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy

NCT02659098

Conditions: Eye Diseases, Geographic Atrophy, Macular Degeneration, +3 more
Locations: Arcadia, California, United States

Chicago, Illinois, United States

Lexington, Kentucky, United States

Boston, Massachusetts, United States

View Trial Details

Completed

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

NCT03815825

Conditions: Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations: IONIS Investigative Site Phoenix, Arizona, United States

IONIS Investigative Site Phoenix, Arizona, United States

IONIS Investigative Site Phoenix, Arizona, United States

IONIS Investigative Site Sun City, Arizona, United States

View all 88 locations

View Trial Details

Macular Degeneration

Macular Degeneration trial results

Related conditions